Identifying the ligand of VSIG4 on T cells would be pivotal for understanding the mechanisms whereby VSIG4 modulates antitumor T-cell responses and is fundamentally important for developing high-efficacy inhibitors that aim to block VSIG4-mediated T-cell suppression in cancer Figure 1. The gene discussed is VSIG4; the disease is cancer.